nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP2E1—Dacarbazine—melanoma	0.153	0.22	CbGbCtD
Bromazepam—CYP1A2—Carmustine—melanoma	0.146	0.21	CbGbCtD
Bromazepam—CYP1A2—Vemurafenib—melanoma	0.115	0.166	CbGbCtD
Bromazepam—CYP3A4—Temozolomide—melanoma	0.11	0.159	CbGbCtD
Bromazepam—CYP1A2—Dacarbazine—melanoma	0.0885	0.127	CbGbCtD
Bromazepam—CYP3A4—Vemurafenib—melanoma	0.0605	0.0871	CbGbCtD
Bromazepam—CYP3A4—Docetaxel—melanoma	0.0208	0.0299	CbGbCtD
Bromazepam—Digestion impaired—Temozolomide—melanoma	0.00386	0.0248	CcSEcCtD
Bromazepam—Aggression—Bleomycin—melanoma	0.00348	0.0224	CcSEcCtD
Bromazepam—Speech disorder—Carmustine—melanoma	0.0031	0.0199	CcSEcCtD
Bromazepam—Speech disorder—Temozolomide—melanoma	0.003	0.0193	CcSEcCtD
Bromazepam—GABRR3—eye—melanoma	0.00295	0.0608	CbGeAlD
Bromazepam—GABRR3—retina—melanoma	0.00292	0.0603	CbGeAlD
Bromazepam—GABRE—hair follicle—melanoma	0.00274	0.0564	CbGeAlD
Bromazepam—Depressed level of consciousness—Carmustine—melanoma	0.00258	0.0166	CcSEcCtD
Bromazepam—GABRR2—eye—melanoma	0.00256	0.0527	CbGeAlD
Bromazepam—GABRR2—retina—melanoma	0.00253	0.0522	CbGeAlD
Bromazepam—Haemoglobin decreased—Docetaxel—melanoma	0.00249	0.016	CcSEcCtD
Bromazepam—Depressed level of consciousness—Temozolomide—melanoma	0.00249	0.016	CcSEcCtD
Bromazepam—Connective tissue disorder—Vemurafenib—melanoma	0.00249	0.016	CcSEcCtD
Bromazepam—GABRA3—neck—melanoma	0.00249	0.0512	CbGeAlD
Bromazepam—GABRR1—eye—melanoma	0.00246	0.0507	CbGeAlD
Bromazepam—GABRR1—retina—melanoma	0.00244	0.0503	CbGeAlD
Bromazepam—Eye disorder—Vemurafenib—melanoma	0.00237	0.0152	CcSEcCtD
Bromazepam—Cardiac disorder—Vemurafenib—melanoma	0.00235	0.0151	CcSEcCtD
Bromazepam—Malnutrition—Vemurafenib—melanoma	0.0022	0.0142	CcSEcCtD
Bromazepam—Diplopia—Carmustine—melanoma	0.00194	0.0124	CcSEcCtD
Bromazepam—Diplopia—Temozolomide—melanoma	0.00187	0.012	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00186	0.012	CcSEcCtD
Bromazepam—Ataxia—Carmustine—melanoma	0.00182	0.0117	CcSEcCtD
Bromazepam—Anaphylactic shock—Vemurafenib—melanoma	0.0018	0.0116	CcSEcCtD
Bromazepam—Nervous system disorder—Vemurafenib—melanoma	0.00176	0.0113	CcSEcCtD
Bromazepam—Ataxia—Temozolomide—melanoma	0.00176	0.0113	CcSEcCtD
Bromazepam—Skin disorder—Vemurafenib—melanoma	0.00175	0.0112	CcSEcCtD
Bromazepam—Muscular weakness—Carmustine—melanoma	0.00171	0.011	CcSEcCtD
Bromazepam—Hypotension—Vemurafenib—melanoma	0.00168	0.0108	CcSEcCtD
Bromazepam—GABRR3—head—melanoma	0.00167	0.0345	CbGeAlD
Bromazepam—GABRQ—head—melanoma	0.00167	0.0345	CbGeAlD
Bromazepam—Muscular weakness—Temozolomide—melanoma	0.00165	0.0106	CcSEcCtD
Bromazepam—Decreased appetite—Vemurafenib—melanoma	0.00156	0.0101	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Vemurafenib—melanoma	0.00155	0.00998	CcSEcCtD
Bromazepam—Fatigue—Vemurafenib—melanoma	0.00155	0.00997	CcSEcCtD
Bromazepam—GABRG3—head—melanoma	0.00147	0.0302	CbGeAlD
Bromazepam—GABRR2—head—melanoma	0.00145	0.0299	CbGeAlD
Bromazepam—GABRA4—mammalian vulva—melanoma	0.00143	0.0295	CbGeAlD
Bromazepam—GABRR1—head—melanoma	0.0014	0.0288	CbGeAlD
Bromazepam—Hallucination—Carmustine—melanoma	0.00133	0.00857	CcSEcCtD
Bromazepam—Hypersensitivity—Vemurafenib—melanoma	0.00133	0.00852	CcSEcCtD
Bromazepam—Connective tissue disorder—Carmustine—melanoma	0.00132	0.00846	CcSEcCtD
Bromazepam—Asthenia—Vemurafenib—melanoma	0.00129	0.0083	CcSEcCtD
Bromazepam—Hallucination—Temozolomide—melanoma	0.00129	0.00828	CcSEcCtD
Bromazepam—Cardiac failure—Docetaxel—melanoma	0.00127	0.00819	CcSEcCtD
Bromazepam—Pruritus—Vemurafenib—melanoma	0.00127	0.00818	CcSEcCtD
Bromazepam—Connective tissue disorder—Temozolomide—melanoma	0.00127	0.00818	CcSEcCtD
Bromazepam—Eye disorder—Carmustine—melanoma	0.00125	0.00805	CcSEcCtD
Bromazepam—GABRD—head—melanoma	0.00121	0.025	CbGeAlD
Bromazepam—Eye disorder—Temozolomide—melanoma	0.00121	0.00777	CcSEcCtD
Bromazepam—Cardiac disorder—Temozolomide—melanoma	0.0012	0.00772	CcSEcCtD
Bromazepam—Dizziness—Vemurafenib—melanoma	0.00119	0.00765	CcSEcCtD
Bromazepam—Mental disorder—Carmustine—melanoma	0.00117	0.00754	CcSEcCtD
Bromazepam—Ataxia—Docetaxel—melanoma	0.00117	0.00752	CcSEcCtD
Bromazepam—GABRG1—head—melanoma	0.00117	0.0241	CbGeAlD
Bromazepam—Malnutrition—Carmustine—melanoma	0.00117	0.00749	CcSEcCtD
Bromazepam—GABRA6—head—melanoma	0.00116	0.024	CbGeAlD
Bromazepam—GABRB3—eye—melanoma	0.00116	0.0239	CbGeAlD
Bromazepam—Vomiting—Vemurafenib—melanoma	0.00114	0.00735	CcSEcCtD
Bromazepam—Rash—Vemurafenib—melanoma	0.00113	0.00729	CcSEcCtD
Bromazepam—Mental disorder—Temozolomide—melanoma	0.00113	0.00729	CcSEcCtD
Bromazepam—GABRB1—head—melanoma	0.00113	0.0234	CbGeAlD
Bromazepam—Dermatitis—Vemurafenib—melanoma	0.00113	0.00729	CcSEcCtD
Bromazepam—GABRA5—head—melanoma	0.00113	0.0232	CbGeAlD
Bromazepam—Headache—Vemurafenib—melanoma	0.00113	0.00725	CcSEcCtD
Bromazepam—Malnutrition—Temozolomide—melanoma	0.00113	0.00724	CcSEcCtD
Bromazepam—Confusional state—Bleomycin—melanoma	0.0011	0.00707	CcSEcCtD
Bromazepam—Vision blurred—Carmustine—melanoma	0.0011	0.00706	CcSEcCtD
Bromazepam—Tremor—Carmustine—melanoma	0.00109	0.00702	CcSEcCtD
Bromazepam—Anaphylactic shock—Bleomycin—melanoma	0.00109	0.00701	CcSEcCtD
Bromazepam—GABRE—mammalian vulva—melanoma	0.00108	0.0223	CbGeAlD
Bromazepam—Agitation—Carmustine—melanoma	0.00107	0.00689	CcSEcCtD
Bromazepam—Nausea—Vemurafenib—melanoma	0.00107	0.00687	CcSEcCtD
Bromazepam—Vision blurred—Temozolomide—melanoma	0.00106	0.00683	CcSEcCtD
Bromazepam—Tremor—Temozolomide—melanoma	0.00106	0.00679	CcSEcCtD
Bromazepam—GABRA3—head—melanoma	0.00105	0.0216	CbGeAlD
Bromazepam—Anorexia—Bleomycin—melanoma	0.00104	0.00668	CcSEcCtD
Bromazepam—Agitation—Temozolomide—melanoma	0.00104	0.00666	CcSEcCtD
Bromazepam—GABRA4—head—melanoma	0.00102	0.0211	CbGeAlD
Bromazepam—Hypotension—Bleomycin—melanoma	0.00102	0.00655	CcSEcCtD
Bromazepam—GABRR2—lymph node—melanoma	0.00102	0.021	CbGeAlD
Bromazepam—GABRP—head—melanoma	0.00102	0.0209	CbGeAlD
Bromazepam—Convulsion—Carmustine—melanoma	0.00101	0.00649	CcSEcCtD
Bromazepam—Palpitations—Temozolomide—melanoma	0.000996	0.0064	CcSEcCtD
Bromazepam—Convulsion—Temozolomide—melanoma	0.000976	0.00627	CcSEcCtD
Bromazepam—Anorexia—Dactinomycin—melanoma	0.000969	0.00623	CcSEcCtD
Bromazepam—Confusional state—Carmustine—melanoma	0.000959	0.00617	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000953	0.00612	CcSEcCtD
Bromazepam—Decreased appetite—Bleomycin—melanoma	0.000948	0.00609	CcSEcCtD
Bromazepam—Dry mouth—Temozolomide—melanoma	0.000938	0.00603	CcSEcCtD
Bromazepam—Tachycardia—Carmustine—melanoma	0.000929	0.00597	CcSEcCtD
Bromazepam—Confusional state—Temozolomide—melanoma	0.000927	0.00596	CcSEcCtD
Bromazepam—Anaphylactic shock—Temozolomide—melanoma	0.00092	0.00591	CcSEcCtD
Bromazepam—Anorexia—Carmustine—melanoma	0.000907	0.00583	CcSEcCtD
Bromazepam—Nervous system disorder—Temozolomide—melanoma	0.000902	0.0058	CcSEcCtD
Bromazepam—Feeling abnormal—Bleomycin—melanoma	0.000898	0.00577	CcSEcCtD
Bromazepam—Skin disorder—Temozolomide—melanoma	0.000893	0.00574	CcSEcCtD
Bromazepam—Hypotension—Carmustine—melanoma	0.000889	0.00572	CcSEcCtD
Bromazepam—Decreased appetite—Dactinomycin—melanoma	0.000884	0.00568	CcSEcCtD
Bromazepam—Fatigue—Dactinomycin—melanoma	0.000877	0.00563	CcSEcCtD
Bromazepam—Anorexia—Temozolomide—melanoma	0.000877	0.00563	CcSEcCtD
Bromazepam—GABRG2—head—melanoma	0.000856	0.0176	CbGeAlD
Bromazepam—GABRB2—head—melanoma	0.000856	0.0176	CbGeAlD
Bromazepam—Somnolence—Carmustine—melanoma	0.000846	0.00544	CcSEcCtD
Bromazepam—Connective tissue disorder—Docetaxel—melanoma	0.000846	0.00544	CcSEcCtD
Bromazepam—Feeling abnormal—Dactinomycin—melanoma	0.000838	0.00539	CcSEcCtD
Bromazepam—Decreased appetite—Carmustine—melanoma	0.000827	0.00532	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Carmustine—melanoma	0.000822	0.00528	CcSEcCtD
Bromazepam—Somnolence—Temozolomide—melanoma	0.000818	0.00525	CcSEcCtD
Bromazepam—Dyspepsia—Temozolomide—melanoma	0.000809	0.0052	CcSEcCtD
Bromazepam—Eye disorder—Docetaxel—melanoma	0.000804	0.00517	CcSEcCtD
Bromazepam—Hypersensitivity—Bleomycin—melanoma	0.000803	0.00516	CcSEcCtD
Bromazepam—Decreased appetite—Temozolomide—melanoma	0.000799	0.00514	CcSEcCtD
Bromazepam—Cardiac disorder—Docetaxel—melanoma	0.000799	0.00513	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Temozolomide—melanoma	0.000794	0.0051	CcSEcCtD
Bromazepam—Fatigue—Temozolomide—melanoma	0.000793	0.0051	CcSEcCtD
Bromazepam—Feeling abnormal—Carmustine—melanoma	0.000784	0.00504	CcSEcCtD
Bromazepam—Asthenia—Bleomycin—melanoma	0.000782	0.00503	CcSEcCtD
Bromazepam—GABRA2—head—melanoma	0.000782	0.0161	CbGeAlD
Bromazepam—GABRE—head—melanoma	0.000775	0.016	CbGeAlD
Bromazepam—Pruritus—Bleomycin—melanoma	0.000771	0.00496	CcSEcCtD
Bromazepam—Feeling abnormal—Temozolomide—melanoma	0.000758	0.00487	CcSEcCtD
Bromazepam—GABRA1—head—melanoma	0.000756	0.0156	CbGeAlD
Bromazepam—Mental disorder—Docetaxel—melanoma	0.000754	0.00485	CcSEcCtD
Bromazepam—Malnutrition—Docetaxel—melanoma	0.000749	0.00482	CcSEcCtD
Bromazepam—Hypersensitivity—Dactinomycin—melanoma	0.000749	0.00481	CcSEcCtD
Bromazepam—Asthenia—Dactinomycin—melanoma	0.000729	0.00469	CcSEcCtD
Bromazepam—Muscle spasms—Docetaxel—melanoma	0.00072	0.00463	CcSEcCtD
Bromazepam—Hypersensitivity—Carmustine—melanoma	0.000701	0.00451	CcSEcCtD
Bromazepam—Vomiting—Bleomycin—melanoma	0.000693	0.00446	CcSEcCtD
Bromazepam—Rash—Bleomycin—melanoma	0.000687	0.00442	CcSEcCtD
Bromazepam—Dermatitis—Bleomycin—melanoma	0.000687	0.00441	CcSEcCtD
Bromazepam—Asthenia—Carmustine—melanoma	0.000683	0.00439	CcSEcCtD
Bromazepam—Hypersensitivity—Temozolomide—melanoma	0.000678	0.00435	CcSEcCtD
Bromazepam—Palpitations—Docetaxel—melanoma	0.000662	0.00426	CcSEcCtD
Bromazepam—Asthenia—Temozolomide—melanoma	0.00066	0.00424	CcSEcCtD
Bromazepam—GABRB3—head—melanoma	0.000657	0.0135	CbGeAlD
Bromazepam—Pruritus—Temozolomide—melanoma	0.000651	0.00418	CcSEcCtD
Bromazepam—Convulsion—Docetaxel—melanoma	0.000649	0.00417	CcSEcCtD
Bromazepam—Nausea—Bleomycin—melanoma	0.000648	0.00416	CcSEcCtD
Bromazepam—Vomiting—Dactinomycin—melanoma	0.000646	0.00416	CcSEcCtD
Bromazepam—Rash—Dactinomycin—melanoma	0.000641	0.00412	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000634	0.00407	CcSEcCtD
Bromazepam—Dizziness—Carmustine—melanoma	0.000629	0.00404	CcSEcCtD
Bromazepam—Dry mouth—Docetaxel—melanoma	0.000624	0.00401	CcSEcCtD
Bromazepam—Confusional state—Docetaxel—melanoma	0.000617	0.00396	CcSEcCtD
Bromazepam—Anaphylactic shock—Docetaxel—melanoma	0.000612	0.00393	CcSEcCtD
Bromazepam—Dizziness—Temozolomide—melanoma	0.000608	0.00391	CcSEcCtD
Bromazepam—Vomiting—Carmustine—melanoma	0.000605	0.00389	CcSEcCtD
Bromazepam—Nausea—Dactinomycin—melanoma	0.000604	0.00388	CcSEcCtD
Bromazepam—Rash—Carmustine—melanoma	0.0006	0.00386	CcSEcCtD
Bromazepam—Nervous system disorder—Docetaxel—melanoma	0.0006	0.00385	CcSEcCtD
Bromazepam—Dermatitis—Carmustine—melanoma	0.000599	0.00385	CcSEcCtD
Bromazepam—Tachycardia—Docetaxel—melanoma	0.000597	0.00384	CcSEcCtD
Bromazepam—Headache—Carmustine—melanoma	0.000596	0.00383	CcSEcCtD
Bromazepam—Skin disorder—Docetaxel—melanoma	0.000594	0.00382	CcSEcCtD
Bromazepam—Vomiting—Temozolomide—melanoma	0.000585	0.00376	CcSEcCtD
Bromazepam—Anorexia—Docetaxel—melanoma	0.000583	0.00375	CcSEcCtD
Bromazepam—Rash—Temozolomide—melanoma	0.00058	0.00373	CcSEcCtD
Bromazepam—Dermatitis—Temozolomide—melanoma	0.000579	0.00372	CcSEcCtD
Bromazepam—Headache—Temozolomide—melanoma	0.000576	0.0037	CcSEcCtD
Bromazepam—Hypotension—Docetaxel—melanoma	0.000571	0.00367	CcSEcCtD
Bromazepam—Nausea—Carmustine—melanoma	0.000565	0.00363	CcSEcCtD
Bromazepam—GABRA2—lymph node—melanoma	0.000547	0.0113	CbGeAlD
Bromazepam—Nausea—Temozolomide—melanoma	0.000546	0.00351	CcSEcCtD
Bromazepam—Somnolence—Docetaxel—melanoma	0.000544	0.00349	CcSEcCtD
Bromazepam—GABRE—lymph node—melanoma	0.000543	0.0112	CbGeAlD
Bromazepam—Dyspepsia—Docetaxel—melanoma	0.000538	0.00346	CcSEcCtD
Bromazepam—Decreased appetite—Docetaxel—melanoma	0.000532	0.00342	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Docetaxel—melanoma	0.000528	0.00339	CcSEcCtD
Bromazepam—Fatigue—Docetaxel—melanoma	0.000527	0.00339	CcSEcCtD
Bromazepam—Feeling abnormal—Docetaxel—melanoma	0.000504	0.00324	CcSEcCtD
Bromazepam—Hypersensitivity—Docetaxel—melanoma	0.000451	0.0029	CcSEcCtD
Bromazepam—Asthenia—Docetaxel—melanoma	0.000439	0.00282	CcSEcCtD
Bromazepam—Pruritus—Docetaxel—melanoma	0.000433	0.00278	CcSEcCtD
Bromazepam—CYP2E1—head—melanoma	0.000418	0.00862	CbGeAlD
Bromazepam—Dizziness—Docetaxel—melanoma	0.000404	0.0026	CcSEcCtD
Bromazepam—Vomiting—Docetaxel—melanoma	0.000389	0.0025	CcSEcCtD
Bromazepam—Rash—Docetaxel—melanoma	0.000386	0.00248	CcSEcCtD
Bromazepam—Dermatitis—Docetaxel—melanoma	0.000385	0.00248	CcSEcCtD
Bromazepam—Headache—Docetaxel—melanoma	0.000383	0.00246	CcSEcCtD
Bromazepam—Nausea—Docetaxel—melanoma	0.000363	0.00233	CcSEcCtD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—melanoma	4.97e-05	0.000492	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPAM—melanoma	4.95e-05	0.00049	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—MDM2—melanoma	4.94e-05	0.000489	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	4.94e-05	0.000489	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	4.92e-05	0.000487	CbGpPWpGaD
Bromazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.91e-05	0.000486	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—melanoma	4.88e-05	0.000483	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—ALB—melanoma	4.84e-05	0.000479	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.82e-05	0.000477	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—melanoma	4.82e-05	0.000477	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—melanoma	4.79e-05	0.000475	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.79e-05	0.000474	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—melanoma	4.76e-05	0.000471	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	4.76e-05	0.000471	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	4.76e-05	0.000471	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	4.72e-05	0.000467	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.7e-05	0.000466	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—HRAS—melanoma	4.68e-05	0.000464	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—melanoma	4.68e-05	0.000463	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—melanoma	4.68e-05	0.000463	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ACER3—melanoma	4.66e-05	0.000461	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—ALB—melanoma	4.61e-05	0.000457	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—ALB—melanoma	4.61e-05	0.000457	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—melanoma	4.59e-05	0.000455	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—HRAS—melanoma	4.59e-05	0.000455	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—HRAS—melanoma	4.52e-05	0.000448	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—melanoma	4.52e-05	0.000447	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—melanoma	4.49e-05	0.000444	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—HRAS—melanoma	4.48e-05	0.000444	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	4.47e-05	0.000443	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—melanoma	4.4e-05	0.000436	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—MAPK1—melanoma	4.38e-05	0.000434	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—MAPK1—melanoma	4.32e-05	0.000428	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—MDM2—melanoma	4.32e-05	0.000427	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—HRAS—melanoma	4.28e-05	0.000424	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—HRAS—melanoma	4.27e-05	0.000423	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—HRAS—melanoma	4.27e-05	0.000423	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—UGT2B10—melanoma	4.26e-05	0.000422	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—HRAS—melanoma	4.23e-05	0.000419	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	4.21e-05	0.000416	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP1B1—melanoma	4.2e-05	0.000416	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	4.14e-05	0.00041	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—AKT1—melanoma	4.14e-05	0.000409	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	4.12e-05	0.000408	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.11e-05	0.000407	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	4.09e-05	0.000405	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—MAPK1—melanoma	4.09e-05	0.000405	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—MAPK1—melanoma	4.03e-05	0.000399	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	4.01e-05	0.000397	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HS3ST5—melanoma	3.96e-05	0.000392	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PLCB4—melanoma	3.89e-05	0.000385	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—HRAS—melanoma	3.87e-05	0.000383	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	3.85e-05	0.000382	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	3.85e-05	0.000381	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—ALB—melanoma	3.8e-05	0.000376	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—HRAS—melanoma	3.76e-05	0.000372	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—ALB—melanoma	3.74e-05	0.000371	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—MAPK1—melanoma	3.69e-05	0.000365	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—HRAS—melanoma	3.69e-05	0.000365	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC6A11—melanoma	3.66e-05	0.000362	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIP4K2A—melanoma	3.66e-05	0.000362	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ACER3—melanoma	3.63e-05	0.000359	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—HRAS—melanoma	3.62e-05	0.000359	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	3.61e-05	0.000357	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—HRAS—melanoma	3.6e-05	0.000357	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—MAPK1—melanoma	3.58e-05	0.000355	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MTAP—melanoma	3.56e-05	0.000352	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—ALB—melanoma	3.54e-05	0.000351	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	3.54e-05	0.00035	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—MAPK1—melanoma	3.52e-05	0.000349	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—HRAS—melanoma	3.52e-05	0.000348	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—ALB—melanoma	3.5e-05	0.000346	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—HRAS—melanoma	3.47e-05	0.000343	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—MAPK1—melanoma	3.46e-05	0.000343	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—MAPK1—melanoma	3.44e-05	0.00034	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—MAPK1—melanoma	3.38e-05	0.000334	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—UGT2B10—melanoma	3.32e-05	0.000329	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—HRAS—melanoma	3.28e-05	0.000325	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	3.28e-05	0.000324	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—HRAS—melanoma	3.24e-05	0.000321	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—ALB—melanoma	3.2e-05	0.000317	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.19e-05	0.000316	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PHGDH—melanoma	3.17e-05	0.000314	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—LUM—melanoma	3.17e-05	0.000314	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HPSE—melanoma	3.11e-05	0.000308	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ALB—melanoma	3.11e-05	0.000308	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	3.09e-05	0.000306	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HS3ST5—melanoma	3.09e-05	0.000305	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CUBN—melanoma	3.05e-05	0.000302	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ALB—melanoma	3.05e-05	0.000302	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLCB4—melanoma	3e-05	0.000297	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ALB—melanoma	3e-05	0.000297	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ALB—melanoma	2.98e-05	0.000295	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—HRAS—melanoma	2.96e-05	0.000293	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—MAPK1—melanoma	2.95e-05	0.000292	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SDHD—melanoma	2.95e-05	0.000292	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CSPG4—melanoma	2.95e-05	0.000292	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—BSG—melanoma	2.95e-05	0.000292	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	2.95e-05	0.000292	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	2.93e-05	0.00029	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—HRAS—melanoma	2.88e-05	0.000285	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GPAM—melanoma	2.85e-05	0.000283	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—HRAS—melanoma	2.83e-05	0.00028	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC6A11—melanoma	2.82e-05	0.000279	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIP4K2A—melanoma	2.82e-05	0.000279	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ACER3—melanoma	2.8e-05	0.000277	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—HRAS—melanoma	2.78e-05	0.000275	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—HRAS—melanoma	2.76e-05	0.000273	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MTAP—melanoma	2.74e-05	0.000272	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—HRAS—melanoma	2.71e-05	0.000268	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.68e-05	0.000266	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—UGT2B10—melanoma	2.56e-05	0.000254	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	2.56e-05	0.000253	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.48e-05	0.000246	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PHGDH—melanoma	2.45e-05	0.000242	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LUM—melanoma	2.45e-05	0.000242	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PLA2G6—melanoma	2.43e-05	0.00024	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HPSE—melanoma	2.4e-05	0.000238	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HS3ST5—melanoma	2.38e-05	0.000236	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—HRAS—melanoma	2.37e-05	0.000234	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CUBN—melanoma	2.35e-05	0.000233	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLCB4—melanoma	2.34e-05	0.000231	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	2.29e-05	0.000227	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SDHD—melanoma	2.27e-05	0.000225	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—BSG—melanoma	2.27e-05	0.000225	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CSPG4—melanoma	2.27e-05	0.000225	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GPAM—melanoma	2.2e-05	0.000218	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIP4K2A—melanoma	2.2e-05	0.000218	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC6A11—melanoma	2.2e-05	0.000218	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—VCAN—melanoma	2.18e-05	0.000216	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MTAP—melanoma	2.14e-05	0.000212	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.09e-05	0.000207	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LUM—melanoma	1.91e-05	0.000189	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PHGDH—melanoma	1.91e-05	0.000189	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLA2G6—melanoma	1.87e-05	0.000185	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HPSE—melanoma	1.87e-05	0.000185	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP17A1—melanoma	1.84e-05	0.000182	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CUBN—melanoma	1.83e-05	0.000182	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLCB4—melanoma	1.8e-05	0.000179	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CSPG4—melanoma	1.77e-05	0.000175	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—BSG—melanoma	1.77e-05	0.000175	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SDHD—melanoma	1.77e-05	0.000175	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GNA11—melanoma	1.74e-05	0.000172	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GPAM—melanoma	1.72e-05	0.00017	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—FASN—melanoma	1.7e-05	0.000168	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIP4K2A—melanoma	1.7e-05	0.000168	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC6A11—melanoma	1.7e-05	0.000168	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—VCAN—melanoma	1.68e-05	0.000167	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC5A5—melanoma	1.67e-05	0.000166	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MTAP—melanoma	1.65e-05	0.000163	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GNAQ—melanoma	1.62e-05	0.00016	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CD44—melanoma	1.62e-05	0.00016	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.59e-05	0.000158	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP1B1—melanoma	1.55e-05	0.000153	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.54e-05	0.000152	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LUM—melanoma	1.47e-05	0.000146	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PHGDH—melanoma	1.47e-05	0.000146	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLA2G6—melanoma	1.46e-05	0.000144	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HPSE—melanoma	1.44e-05	0.000143	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP17A1—melanoma	1.42e-05	0.000141	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CUBN—melanoma	1.42e-05	0.00014	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.4e-05	0.000139	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.38e-05	0.000137	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CSPG4—melanoma	1.37e-05	0.000135	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SDHD—melanoma	1.37e-05	0.000135	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—BSG—melanoma	1.37e-05	0.000135	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GNA11—melanoma	1.34e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GPAM—melanoma	1.32e-05	0.000131	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—FASN—melanoma	1.31e-05	0.00013	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—VCAN—melanoma	1.31e-05	0.00013	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC5A5—melanoma	1.29e-05	0.000128	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ABCB1—melanoma	1.28e-05	0.000126	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GNAQ—melanoma	1.25e-05	0.000123	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CD44—melanoma	1.25e-05	0.000123	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.24e-05	0.000123	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.22e-05	0.000121	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.21e-05	0.00012	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.2e-05	0.000119	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP1B1—melanoma	1.19e-05	0.000118	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PRKCA—melanoma	1.17e-05	0.000116	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ERCC2—melanoma	1.16e-05	0.000115	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLA2G6—melanoma	1.13e-05	0.000111	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP17A1—melanoma	1.11e-05	0.000109	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.09e-05	0.000108	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.08e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.05e-05	0.000104	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GNA11—melanoma	1.04e-05	0.000103	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—FASN—melanoma	1.02e-05	0.000101	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—VCAN—melanoma	1.01e-05	0.0001	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC5A5—melanoma	1.01e-05	9.95e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ABCB1—melanoma	9.84e-06	9.74e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GNAQ—melanoma	9.71e-06	9.61e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CD44—melanoma	9.71e-06	9.61e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.51e-06	9.41e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.42e-06	9.33e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP1B1—melanoma	9.31e-06	9.22e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CG—melanoma	9.19e-06	9.1e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PRKCA—melanoma	9.05e-06	8.96e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ERCC2—melanoma	8.98e-06	8.89e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPARG—melanoma	8.87e-06	8.78e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP17A1—melanoma	8.54e-06	8.45e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.22e-06	8.13e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CD—melanoma	8.08e-06	8e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GNA11—melanoma	8.06e-06	7.98e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALB—melanoma	7.98e-06	7.9e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—FASN—melanoma	7.89e-06	7.81e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC5A5—melanoma	7.76e-06	7.68e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCB1—melanoma	7.67e-06	7.59e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CD44—melanoma	7.49e-06	7.42e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GNAQ—melanoma	7.49e-06	7.42e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.44e-06	7.36e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP1B1—melanoma	7.18e-06	7.11e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CG—melanoma	7.09e-06	7.02e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PRKCA—melanoma	7.05e-06	6.98e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CB—melanoma	7.04e-06	6.97e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ERCC2—melanoma	7e-06	6.93e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS2—melanoma	6.98e-06	6.91e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPARG—melanoma	6.84e-06	6.78e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CD—melanoma	6.23e-06	6.17e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALB—melanoma	6.15e-06	6.09e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTEN—melanoma	6.09e-06	6.03e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCB1—melanoma	5.92e-06	5.86e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.8e-06	5.74e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CG—melanoma	5.53e-06	5.47e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PRKCA—melanoma	5.44e-06	5.39e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CB—melanoma	5.43e-06	5.38e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ERCC2—melanoma	5.4e-06	5.35e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS2—melanoma	5.38e-06	5.33e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPARG—melanoma	5.33e-06	5.28e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CD—melanoma	4.86e-06	4.81e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALB—melanoma	4.8e-06	4.75e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTEN—melanoma	4.7e-06	4.65e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CA—melanoma	4.29e-06	4.25e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CG—melanoma	4.26e-06	4.22e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CB—melanoma	4.23e-06	4.19e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS2—melanoma	4.2e-06	4.15e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPARG—melanoma	4.12e-06	4.07e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CD—melanoma	3.75e-06	3.71e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALB—melanoma	3.7e-06	3.66e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTEN—melanoma	3.66e-06	3.62e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—AKT1—melanoma	3.51e-06	3.47e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CA—melanoma	3.31e-06	3.28e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CB—melanoma	3.27e-06	3.24e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS2—melanoma	3.24e-06	3.21e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTEN—melanoma	2.82e-06	2.8e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—AKT1—melanoma	2.71e-06	2.68e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CA—melanoma	2.58e-06	2.56e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—AKT1—melanoma	2.11e-06	2.09e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CA—melanoma	1.99e-06	1.97e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—AKT1—melanoma	1.63e-06	1.61e-05	CbGpPWpGaD
